<!DOCTYPE html>
<html lang="en-gb" dir="ltr">

  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Novogen</title>
    <link rel="apple-touch-icon" sizes="57x57" href="img/favicons/apple-touch-icon-114x114.png">
    <link rel="apple-touch-icon" sizes="114x114" href="img/favicons/apple-touch-icon-114x114.png">
    <link rel="apple-touch-icon" sizes="72x72" href="img/favicons/apple-touch-icon-72x72.png">
    <link rel="apple-touch-icon" sizes="144x144" href="img/favicons/apple-touch-icon-144x144.png">
    <link rel="apple-touch-icon" sizes="60x60" href="img/favicons/apple-touch-icon-60x60.png">
    <link rel="apple-touch-icon" sizes="120x120" href="img/favicons/apple-touch-icon-120x120.png">
    <link rel="apple-touch-icon" sizes="76x76" href="img/favicons/apple-touch-icon-76x76.png">
    <link rel="apple-touch-icon" sizes="152x152" href="img/favicons/apple-touch-icon-152x152.png">
    <link rel="apple-touch-icon" sizes="180x180" href="img/favicons/apple-touch-icon-180x180.png">
    <link rel="icon" type="image/png" href="img/favicons/favicon-192x192.png" sizes="192x192">
    <link rel="icon" type="image/png" href="img/favicons/favicon-160x160.png" sizes="160x160">
    <link rel="icon" type="image/png" href="img/favicons/favicon-96x96.png" sizes="96x96">
    <link rel="icon" type="image/png" href="img/favicons/favicon-16x16.png" sizes="16x16">
    <link rel="icon" type="image/png" href="img/favicons/favicon-32x32.png" sizes="32x32">
    <meta name="msapplication-TileColor" content="#21c4c2">
    <meta name="msapplication-TileImage" content="img/favicons/mstile-144x144.png">
    <link href="//maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css" rel="stylesheet">
    <link href='http://fonts.googleapis.com/css?family=Raleway:400,300,500' rel='stylesheet' type='text/css'>
    <link rel="stylesheet" href="bower_components/uikit/css/mystyle.css">
    <script src="bower_components/jquery/dist/jquery.min.js"></script>
    <script src="bower_components/uikit/js/uikit.min.js"></script>
    <script src="bower_components/uikit/js/core/offcanvas.min.js"></script>
    <script src="bower_components/uikit/js/components/slideshow.min.js"></script>
    <script src="bower_components/uikit/js/components/slideshow-fx.min.js"></script>
    <script src="bower_components/uikit/js/components/cover.min.js"></script>
    <script src="bower_components/uikit/js/components/sticky.min.js"></script>
  </head>

  <body>
    <div class="social-bar uk-vertical-align">
      <div class="share-icons uk-vertical-align-middle uk-grid uk-width-1-1">
        <span class="share-wrap uk-width-1-2">
          <a href="http://www.nasdaq.com/symbol/nvgn/sec-filings" target="_blank"><img src="img/nasdaq.svg" class="nasdaq-top">
            <a href="http://www.asx.com.au/asx/research/companyInfo.do?by=asxCode&asxCode=NRT" target="_blank"><img src="img/ASX.svg" class="asx-top "></a>
            </span>
          <span class="social-wrap uk-width-1-2">
            <a href="https://twitter.com/Novogen" target="_blank"><img src="img/twitter.png" class="twitter-top uk-float-right"></a>
            <a href="https://www.linkedin.com/company/novogen" target="_blank"><img src="img/LinkedIn.svg" class="linkedin-top uk-float-right"></a>
            <a href="https://www.youtube.com/channel/UCzNMflCMfqL-kTzanKU-gDQ" target="_blank"><img src="img/youtube.svg" class="utube-top uk-float-right"></a>
          </span>
          </div>

      </div>
      <nav class="uk-navbar uk-navbar-attached" data-uk-sticky>
        <a class="logo uk-navbar-brand" href="index.html"><img src="img/novogen-white.svg" alt="Novogen Logo with white writing on dark background"></a>
        <ul class="uk-navbar-nav uk-navbar-flip uk-hidden-small">
          <li class="menu-item" data-uk-dropdown><a href="about.html">About</a>
            <div class="uk-dropdown uk-dropdown-navbar">
              <ul class="uk-nav uk-nav-navbar">
                <li><a href="#">History</a></li>
                <li><a href="#">Vision</a></li>
                <li><a href="#">CEO</a></li>
                <li><a href="theboard.html">The Board</a></li>
                <li><a href="executive.html">Executive Team</a></li>
              </ul>
            </div>
          </li>
          <li class="menu-item" data-uk-dropdown><a href="programs.html">Progams</a>

            <div class="longer-list uk-dropdown uk-dropdown-navbar">
              <ul class="uk-nav uk-nav-navbar">
                <li><a href="">SUPER-BENZOPYRAN DRUG TECHNOLOGY</a></li>
                <li><a href="">ANTI-TROPOMYOSINS DRUG TECHNOLOGY</a></li>
                <li><a href="">CANTX PROGRAM</a></li>
                <li><a href="">PROJECT JACOB HOPE</a></li>
              </ul>
            </div>

          </li>
          <li class="menu-item" data-uk-dropdown><a href="investors.html">Investors</a>
            <div class="long-list uk-dropdown uk-dropdown-navbar">
              <ul class="uk-nav uk-nav-navbar">
                <li><a href="">LATEST PRESENTATIONS</a></li>
                <li><a href="">MEDIA</a></li>
                <li><a href="">NEWSLETTERS</a></li>
                <li><a href="">MEIP IN-SPECIE DISTRIBUTION</a></li>
                <li><a href="">CORPORATE GOVERNANCE</a></li>
                <li><a href="">SHARE PRICE</a></li>
              </ul>
            </div>
          </li>
          <li class="menu-item"><a href="contact.html">Contact</a></li>
        </ul>
        <a href="#mobi-nav" class="uk-navbar-toggle uk-visible-small uk-float-right" data-uk-offcanvas>MENU </a>
      </nav>
      <div id="mobi-nav" class="uk-offcanvas">


        <div class="uk-offcanvas-bar">

          <ul class="uk-nav uk-nav-offcanvas uk-nav-parent-icon" data-uk-nav>
            <li><a href="">MENU</a></li>
            <li class="uk-active"><a href="index.html">HOME</a></li>

            <li class="uk-parent">
              <a href="about.html">ABOUT</a>
              <ul class="uk-nav-sub">
                <li><a href="#">HISTORY</a></li>
                <li><a href="#">VISION</a></li>
                <li><a href="#">CEO</a></li>
                <li><a href="theboard.html">THE BOARD</a></li>
                <li><a href="executive.html">EXECUTIVE TEAM</a></li>
              </ul>
            </li>

            <li class="uk-parent">
              <a href="progams.html">PROGRAMS</a>
              <ul class="uk-nav-sub">
                <li><a href="">SUPER-BENZOPYRAN DRUG TECHNOLOGY</a></li>
                <li><a href="">ANTI-TROPOMYOSINS DRUG TECHNOLOGY</a></li>
                <li><a href="">CANTX PROGRAM</a></li>
                <li><a href="">PROJECT JACOB HOPE</a></li>
              </ul>
            </li>
            <li class="uk-parent">
              <a href="investors.html">INVESTORS</a>
              <ul class="uk-nav-sub">
                <li><a href="">LATEST PRESENTATIONS</a></li>
                <li><a href="">MEDIA</a></li>
                <li><a href="">NEWSLETTERS</a></li>
                <li><a href="">MEIP IN-SPECIE DISTRIBUTION</a></li>
                <li><a href="">CORPORATE GOVERNANCE</a></li>
                <li><a href="">SHARE PRICE</a>
                  <ul>
                    <li><a href="" target="_blank">ASX</a></li>
                    <li><a href="" target="_blank">Nasdaq</a></li>
                  </ul>
                </li>
              </ul>
            </li>

            <li class="uk-nav-header">Connect with us</li>
            <li><a href="contact.html"><i class="uk-icon-envelope-o"></i> Contact</a></li>
            <li><a href="https://www.youtube.com/channel/UCzNMflCMfqL-kTzanKU-gDQ" target="_blank"><i class="uk-icon-youtube"></i> YouTube</a></li>
            <li><a href="https://twitter.com/Novogen" target="_blank"><i class="uk-icon-twitter"></i> Twitter</a></li>
            <li><a href="https://www.linkedin.com/company/novogen" target="_blank"><i class="uk-icon-linkedin"></i> LinkedIn</a></li>
            <!--
<li class="uk-nav-divider"></li>
<li><a href=""><i class="uk-icon-rss"></i> Item</a></li>
-->
          </ul>

        </div>

      </div>

      <div class="about-top uk-vertical-align">
        <div class="uk-vertical-align-middle">
          <h1>The Board of Directors</h1>
        </div>
      </div>

      <div class="board-member">
        <div class="bm"><img src="img/gkLg.png"></div>
        <div class="bm-topline-wrap">
          <div class="bm-topline"></div>
          <div class="bm-heading">
            <h2 class="uk-margin-bottom-remove">Dr Graham Kelly</h2>
            <h4 class="uk-margin-top-remove">
              B.Sc(Hons),B.VSc(Hons)
              <br>Executive Director &amp; CEO
            </h4>
          </div>
        </div>
        <div class="bm-box uk-visible-large"></div>

        <div class="bm-bottom-line"></div>
      </div>
      <div class="bm-text">
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.<p>Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.<br>Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.
          Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.
          Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
      </div>
      <div class="double-lines"></div>

      <div class="board-member-right">
       <div class="bm-right"><img src="img/jpOconnor.png"><div class="bm-right-bottom-line"></div></div>
        <div class="bm-topline-right-wrap">
        <div class="bm-right-topline"></div>
        <div class="bm-right-heading">
        <h2 class="uk-margin-bottom-remove">Dr Graham Kelly</h2>
            <h4 class="uk-margin-top-remove">
              B.Sc(Hons),B.VSc(Hons)
              <br>Executive Director &amp; CEO
            </h4>
          </div>
        </div>

        <div class="bm-right-box uk-visible-large"></div>

<div class="bm-right-text uk-clearfix">
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.<p>Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.<br>Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.
          Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.
          Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
      </div>
</div>





             <div class="double-lines"></div>

        </div>
<!--      </div>-->





      <div class="board-member">
        <div class="bm"><img src="img/gkLg.png"></div>
        <div class="bm-topline-wrap">
          <div class="bm-topline"></div>
          <div class="bm-heading">
            <h2 class="uk-margin-bottom-remove">Dr Graham Kelly</h2>
            <h4 class="uk-margin-top-remove">
              B.Sc(Hons),B.VSc(Hons)
              <br>Executive Director &amp; CEO
            </h4>
          </div>
        </div>
        <div class="bm-box uk-visible-large"></div>

        <div class="bm-bottom-line"></div>
      </div>
      <div class="bm-text">
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.<p>Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.<br>Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.
          Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.
          Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
      </div>
      <div class="double-lines"></div>


       <div class="boardmember-right">
      <div class="boardmember-box uk-hidden-small"></div>
      <div class="boardmember-topline"></div>
      <div class="boardmember-image-container"><img class="boardmember-img uk-align-right" src="img/pGunning.png"
      ></div>
      </div>
            <div class="boardmember-bottomline"></div>


      <div class="bm-text">
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.<p>Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.<br>Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
        <p>
          Dr Kelly is the founder and previous CEO and Chairman of ASX-listed and NASDAQ-listed companies, Novogen Ltd and Marshall Edwards Inc. Both companies were built on the concept of benzopyran drug technology that emanated from his 25 years in cancer research in the Department of Surgery, The University of Sydney, and the German Central Cancer Research Institute, Heidelberg, (Germany) and for which he held all relevant patents.
          Dr Kelly personally oversaw the design and implementation of thirty-three Phase I and II clinical trials, and a multi-national Phase III trial in conjunction with the US FDA.
          Dr Kelly has been awarded an Adjunct Professorship by the University of Sydney.
        </p>
      </div>
      <div class="double-lines"></div>

      <footer>
        <div class="uk-grid" style="margin-top: 0">
          <div class="footer-links uk-width-1-2 uk-width-medium-1-4  uk-vertical-align uk-vertical-align-middle">
            <ul class="uk-list">
              <li><a href="#">Home</a></li>
              <li><a href="#">About</a><li>
              <li><a href="#">Programs</a></li>
              <li><a href="#">Investors</a></li>
            </ul>
          </div>
          <ul class="shares-footer uk-list uk-list-space uk-hidden-small uk-width-medium-1-4  uk-vertical-align uk-vertical-align-middle">
            <li><a href="http://www.asx.com.au/asx/research/companyInfo.do?by=asxCode&asxCode=NRT" target="_blank"><img src="img/ASX.svg"></a></li>
            <li><a href="http://www.nasdaq.com/symbol/nvgn/sec-filings" target="_blank"><img src="img/nasdaq.svg"></a></li>
          </ul>
          <div class="uk-width-1-2 uk-width-medium-1-4  uk-vertical-align uk-vertical-align-middle">
            <!--
<form class="uk-form">

<fieldset data-uk-margin>
<legend>Sign up to stay informed</legend>
<input type="text" placeholder="you@email.com">
<button class="uk-button">SUBMIT</button>
</fieldset>

</form>
-->

            <form class="uk-form" name="catwebformform83042" method="post" onsubmit="return checkWholeForm83042(this)" enctype="multipart/form-data" action="/FormProcessv2.aspx?WebFormID=84800&OID={module_oid}&OTYPE={module_otype}&EID={module_eid}&CID={module_cid}">
              <fieldset data-uk-margin> <legend> Sign up to stay informed</legend>
                <table class="webform" cellspacing="0" cellpadding="2" border="0"><tr><td><input type="text" placeholder="you@email.com" name="EmailAddress" id="EmailAddress" class="cat_textbox" style="width: 169px" maxlength="255"/> </td></tr><tr><td><input class="cat_button uk-button" type="submit" value="Submit" id="catwebformbutton" /></td></tr></table>
              </fieldset>
              <script type="text/javascript" src="/CatalystScripts/ValidationFunctions.js"></script><script type="text/javascript">
              //<![CDATA[
              var submitcount83042 = 0;function checkWholeForm83042(theForm){var why = "";if (theForm.EmailAddress) why += checkEmail(theForm.EmailAddress.value); if(why != ""){alert(why);return false;}if(submitcount83042 == 0){submitcount83042++;theForm.submit();return false;}else{alert("Form submission is in progress.");return false;}}
              //]]>
              </script></form>



          </div>
          <ul class="social-footer uk-list uk-list-space uk-hidden-small uk-width-medium-1-4 ">
            <li><a href="https://twitter.com/Novogen" target="_blank"><img src="img/twitter.png" class="twitter-bottom uk-align-right"></a></li>
            <li><a href="https://www.linkedin.com/company/novogen" target="_blank"><img src="img/LinkedIn.svg" class="linkedin-bottom uk-align-right"></a></li>
            <li><a href="https://www.youtube.com/channel/UCzNMflCMfqL-kTzanKU-gDQ" target="_blank"><img src="img/youtube.svg" class="utube-bottom uk-align-right"></a></li>
          </ul>

        </div>
      </footer>

      </body>
    </html>
